Soricimed Biopharma Inc. — Form D
Soricimed Biopharma Inc. of MONCTON, A3, a company, filed a Form D exempt-offering notice with the SEC on 2011-10-18. The offering totals $109K, of which $109K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-10-18
- Form: D
- Accession: 0001532755-11-000001
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $109K
- Amount sold: $109K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2011-09-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-167442
Issuer
- Name: Soricimed Biopharma Inc.
- CIK: 0001532755
- Entity type: Corporation
- Jurisdiction: NEW BRUNSWICK, CANADA
- Address: 18 BOTSFORD STREET, MONCTON, A3, E1C 4W7
- Phone: (506) 856-0400
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Robert Bruce | Executive Officer | Las Vegas, NV |
| Marc Rubin | Director | Denver, CO |
| Paul Gunn | Director | MONCTON, A3 |
| Paul Gunn | Executive Officer | MONCTON, A3 |
| Camille Belliveau | Director | MONCTON, A3 |
| Susan Hicks | Director | MONCTON, A3 |
| Jack Stewart | Director | MONCTON, A3 |
| Jack Stewart | Executive Officer | MONCTON, A3 |
| Vaughn Embro-Pantelony | Director | MONCTON, A3 |
| Tom Reeves | Director | MONCTON, A3 |
Other filings by this issuer (2)
More